Cannabidiol for Alcoholism

"This study is inviting participants aged between 21 and 60 years old."

"Presently, there are 79 trials involving Cannabidiol and 16 of them have advanced to the third phase. Trials for this drug can be found in multiple locations across Brazil, with a particularly high concentration around Ribeirao Preto and Sao Paulo."

"This trial is searching for 45 individuals between the ages of 21 and 60 who have an alcohol drinking habit that meets DSM-V criteria as a moderate Alcohol Use Disorder (AUD). Participants should also report having had at least one heavy drinking day within the week prior to screening. Additionally, male applicants must consume no less than 21 standard drinks per week while females need 14 or more drinks per week. Lastly, patients must reside in close proximity to the medical centre; within 35 miles of its location."

"Affirmative. Information on clinicaltrials.gov reveals that this experiment, which was initially posted on August 30th 2021, is actively searching for participants. 45 individuals need to be enrolled from 1 medical centre in total."

"Affirmative, clinicaltrials.gov has details to support that this medical trial is currently enrolling volunteers. The experiment was initiated on August 30th 2021 and most recently updated on February 22nd 2022. 45 patients are needed for the study at 1 site of operation."

"The primary outcome metric of this trial, measured within a 4-8 week window, is Alcohol Dependence/Craving. Secondary outcomes include the Beck Anxiety Inventory (scores range from 0 to 63), Pittsburgh Sleep Quality Index (scores range from 0 to 21) and McGill Pain Questionnaire (scores range from 0 to 78). These metrics measure anxiety levels, sleep quality and subjective pain level respectively."

"We rate cannabidiol's safety with a score of 2. Even though it is undergoing phase 2 trials, there is evidence that suggests its innocuousness and lack of data suggesting efficacy."